Injection of 1000 HNSCC CSCs that were ALDH+CD44+ let to tumor development in 13 of 15 mice, while injection of 10,000 non-CSCs which were ALDH−CD44− only led to tumor development in 2 of 15 mice [10]. This evidence concerns the gene CD44 and head and neck squamous cell carcinoma.